Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients

Transplantation

Volumn 87, Issue 1, 2009, Pages 103-111

  Schumann, Alexandra ^a   Lindemann, Monika ^a   Valentin Gamazo, Camino ^a   Lu, Mengji ^a   Elmaagacli, Ahmet ^a   Dahmen, Uta ^a   Knop, Dietmar ^a   Broelsch, Christoph E ^a   Grosse Wilde, Hans ^a   Roggendorf, Michael ^a   Fiedler, Melanie ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Adoptive immune transfer; HBV; Living liver transplantation

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HUMORAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT HEPATITIS B VACCINE; SCI B VAC; TACROLIMUS; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; IMMUNOLOGY; MIDDLE AGED;

ADOPTIVE TRANSFER; ADULT; FEMALE; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 58949104637     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818bfc85     Document Type: Article

References (33)

1. Hoofnagle JH,diBisceglie AM. The treatmentofchronic viral hepatitis. N Engl J Med 1997; 336: 347.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733.
3. O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implications. J Hepatol 1992; 14: 104.
4. Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lami-vudine and hepatitis B immune globulin. Hepatology 1998; 28: 585.
5. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
6. Dumortier J, Chevallier P, Scoazec JY, et al. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: Long-term results. Am J Transplant 2003; 3: 999.
7. Gane EJ, Angus PW, Strasser S, et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007; 132: 931.
8. Ilan Y, Nagler A, Adler R, et al. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993; 104: 1818.
9. Ilan Y, Nagler A, Zeira E, et al. Maintenance of immune memory to the hepatitis Benvelope protein following adoptive transferofimmunity in bone marrow transplant recipients. Bone Marrow Transplant 2000; 26: 633.
10. Lindemann M, Barsegian V, Runde V, et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 2003; 75: 833.
11. Shouval D. Role of vaccination and adoptive immune transfer in persistent hepatitis B virus infection. Indian J Gastroenterol 2001; 20(suppl 1): C55.
12. Dahmen U, Li J,GuY, et al. The efficiency ofhumoral immune transfer depends on both the graft and the immunosuppressive treatment. Transpl Int 2003; 16: 161.
13. Dahmen U, Dirsch O, Li J, et al. Adoptive transfer of immunity: A new strategy to interfere with severe hepatitis virus reinfection after wood-chuck liver transplantation. Transplantation 2004; 77: 965.
14. Lo CM, Fung JT, Lau GK, et al. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology 2003; 37: 36.
15. Luo Y, Lo CM, Cheung CK, et al. Identification of hepatitis B virus-specific lymphocytes inhuman liver grafts from HBV-immune donors. Liver Transpl 2007; 13: 71.
16. Andre FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8(suppl):S74; discussion S79.
17. Kubba AK, Taylor P, Graneek B, et al. Non-responders to hepatitis B vaccination: A review. Commun Dis Public Health 2003; 6: 106.
18. Bienzle U, Gunther M, Neuhaus R, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811.
19. Raz R, Koren R, Bass D. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults. Isr Med Assoc J 2001; 3: 328.
20. Rendi-Wagner P, Shouval D, Genton B, et al. Comparative immuno-genicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine 2006; 24: 2781.
21. Schumann A, Fiedler M, Dahmen U, et al. Cellular and humoral immune response to a third generation hepatitis B vaccine. J Viral Hepat 2007; 14: 592.
22. Beckebaum S, Cicinnati VR, Gerken G, et al. Treatment of hepatitis B reinfection after liver transplantation. Minerva Chir 2003; 58: 705.
23. Partovi N, Guy MW, Ensom MH, et al. A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. Am J Transplant 2001; 1: 51.
24. Birkett D. Pharmacokinetics Made Easy (Revised ed.). Sydney, Australia, McGraw-Hill 2002.
25. Zhang JM, Xu Y, Wang XY, et al. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 2007; 44: 1161.
26. Koldehoff M, Steckel NK, Hlinka M, et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Am J Hematol 2006; 81: 735.
27. Broelsch ChE, Frilling A, Nadalin S, et al. [Living organ donor transplantation - The German experience in comparison to others]. Chirurg 2003; 74: 510.
28. Jonsson JR, Hogan PG, Thomas R, et al. Peripheral blood chimerism following human liver transplantation. Hepatology 1997; 25: 1233.
29. Ueda M, Hundrieser J, Hisanaga M, et al. Development of microchi-merism in pediatric patients after living-related liver transplantation. Clin Transplant 1997; 11: 193.
30. Dahmen UM, Boettcher M, Krawczyk M, et al. Flow cytometric "rare event analysis": A standardized approach to the analysis of donor cell chimerism. J Immunol Methods 2002; 262: 53.
31. Tassignon J, Burny W, Dahmani S, et al. Monitoring of cellular responses after vaccination against tetanus toxoid: Comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR. J Immunol Methods 2005; 305: 188.
32. Bauer T, Gunther M, Bienzle U, et al. Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl 2007; 13: 434.
33. Lo CM, Lau GK, Chan SC, et al. Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Am J Transplant 2007; 7: 434.